Using preference based measures in mental health conditions: The psychometric validity of the EQ-5D and SF-6D
暂无分享,去创建一个
Brendan Mulhern | John Brazier | Djøra I. Soeteman | Clara Mukuria | Michael Barkham | Sarah Byford | M. Barkham | J. Brazier | M. Knapp | S. Byford | B. Mulhern | C. Mukuria | D. Soeteman | Martin Knapp | Martin Knapp
[1] P. Lachenbruch. Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .
[2] B. Mowry,et al. Structured interview for DSM-IV personality: SIDP-IV , 1998 .
[3] S. Kay,et al. The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.
[4] R. Verheul,et al. The burden of disease in personality disorders: diagnosis-specific quality of life. , 2008, Journal of personality disorders.
[5] O C Ukoumunne,et al. Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach , 2003, Psychological Medicine.
[6] T. T. Haug,et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. , 2002, Journal of psychosomatic research.
[7] A. David,et al. Adherence therapy for people with schizophrenia , 2006, British Journal of Psychiatry.
[8] T. Johnson,et al. The MATISSE study: a randomised trial of group art therapy for people with schizophrenia , 2010, BMC psychiatry.
[9] R. Liberman,et al. Brief Psychiatric Rating Scale (BPRS) Expanded Version (4.0): Scales, Anchor Points, and Administration Manual , 1993 .
[10] Peter B. Jones,et al. Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ–5D , 2009, British Journal of Psychiatry.
[11] D. Lamping,et al. Estimating preference-based single index measures for dementia using DEMQOL and DEMQOL-Proxy. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[12] Stefan Leucht,et al. What does the PANSS mean? , 2005, Schizophrenia Research.
[13] R. Brooks. EuroQol: the current state of play. , 1996, Health policy.
[14] P. Dolan,et al. Modeling valuations for EuroQol health states. , 1997, Medical care.
[15] J. Catalan,et al. Differential effects of manual assisted cognitive behavior therapy in the treatment of recurrent deliberate self-harm and personality disturbance: the POPMACT study. , 2004, Journal of personality disorders.
[16] J. Brazier,et al. The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.
[17] T. Brugha,et al. Clinical effectiveness of health visitor training in psychologically informed approaches for depression in postnatal women: pragmatic cluster randomised trial in primary care , 2009, BMJ : British Medical Journal.
[18] M. Barkham,et al. Towards a standardised brief outcome measure: Psychometric properties and utility of the CORE–OM , 2002, British Journal of Psychiatry.
[19] J. Brazier,et al. A checklist for judging preference-based measures of health related quality of life: learning from psychometrics. , 1999, Health economics.
[20] M. Barkham,et al. Suitability and utility of the CORE–OM and CORE–A for assessing severity of presenting problems in psychological therapy services based in primary and secondary care settings , 2005, British Journal of Psychiatry.
[21] R. Snaith,et al. The hospital anxiety and depression scale. , 2013, Acta psychiatrica Scandinavica.
[22] M. Barkham,et al. The rationale for developing and implementing core outcome batteries for routine use in service settings and psychotherapy outcome research , 1998 .
[23] W. Stiles,et al. Stability of the CORE-OM and the BDI-I prior to therapy: evidence from routine practice. , 2007, Psychology and psychotherapy.
[24] Michael Barkham,et al. CORE: Clinical Outcomes in Routine Evaluation , 2000 .
[25] John Brazier,et al. How Valid and Responsive Are Generic Health Status Measures, such as EQ-5D and SF-36, in Schizophrenia? A Systematic Review , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[26] J. Brazier. Is the EQ–5D fit for purpose in mental health? , 2010, British Journal of Psychiatry.
[27] W. Cleveland. Robust Locally Weighted Regression and Smoothing Scatterplots , 1979 .
[28] G. Baker,et al. The development of a QALY measure for epilepsy: NEWQOL-6D , 2012, Epilepsy & Behavior.
[29] M. Barkham,et al. Service profiling and Outcomes benchmarking using the CORE-OM: toward practice-based evidence in the psychological therapies : Patient-Focused Research , 2001 .
[30] J. Brazier,et al. The Estimation of a Preference-Based Measure of Health From the SF-12 , 2004, Medical care.
[31] J. Brazier,et al. A systematic review of the validity and responsiveness of EQ-5D and SF-6D for depression and anxiety , 2012 .
[32] C. Terwee,et al. On assessing responsiveness of health-related quality of life instruments: Guidelines for instrument evaluation , 2003, Quality of Life Research.
[33] Stefan Leucht,et al. Clinical implications of Brief Psychiatric Rating Scale scores. , 2005, The British journal of psychiatry : the journal of mental science.
[34] M. Barkham,et al. Diagnosing depression in primary care using self-completed instruments: UK validation of PHQ-9 and CORE-OM. , 2007, The British journal of general practice : the journal of the Royal College of General Practitioners.
[35] Lewis A. Opler,et al. Reliability and validity of the positive and negative syndrome scale for schizophrenics , 1988, Psychiatry Research.
[36] John Brazier,et al. Measuring and valuing mental health for use in economic evaluation , 2008, Journal of health services research & policy.
[37] G. Bonsel,et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.
[38] R. Timman,et al. Assessment of the burden of disease among inpatients in specialized units that provide psychotherapy. , 2005, Psychiatric services.
[39] M. Barkham,et al. Using Rasch analysis to form plausible health states amenable to valuation: the development of CORE-6D from a measure of common mental health problems (CORE-OM) , 2011, Quality of Life Research.
[40] Michael J. Campbell,et al. Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine , 2006, British Journal of Psychiatry.
[41] D. Lamping,et al. Improving the measurement of QALYs in dementia: developing patient- and carer-reported health state classification systems using Rasch analysis. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.